Research Chems Australia has now closed.
All orders and pre-orders placed before closing will be fulfilled.
We are incredibly grateful for all your support and if you have any questions please reach out to support@researchchemsaustralia.com.au.
- The RCA Team
Mitochondrial-derived peptide for metabolic and cellular energy research.
SKU: MOTSC-10MG
MOTS-c is a mitochondrial-derived peptide studied for metabolic regulation and exercise performance, shipped same business day from Melbourne with free express shipping on orders over $200.
MOTS-c is the first mitochondrial-derived peptide to reach clinical investigation, with ongoing studies exploring its potential in metabolic disease and aging. MOTS-c levels decline naturally with age, correlating with decreased metabolic flexibility and physical capacity.
MOTS-c acts as a mitochondrial signaling peptide that regulates cellular energy metabolism:
| Mechanism | Action | Metabolic Effect |
|---|---|---|
| AMPK Activation | Energy sensor engagement | Enhanced glucose uptake |
| Nuclear Translocation | Stress-responsive gene regulation | Adaptive metabolism |
| Folate-AICAR Pathway | De novo purine synthesis inhibition | Metabolic flexibility |
| Exercise Response | Upregulated by physical activity | Endurance enhancement |
MOTS-c is unique among metabolic peptides in its ability to translocate to the nucleus under stress conditions, directly regulating gene expression in response to metabolic demand.
MOTS-c is being studied for its potential effects on:
Clinical trials are investigating MOTS-c in obesity and fatty liver disease (NCT03998514).
There are many research peptide suppliers in Australia. Here's what sets us apart:
Common questions about MOTS-c
FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. This product is intended for laboratory and research purposes only. Not for human or animal consumption.
Based on 0 reviews
Be the first to review MOTS-c
